The Staggering Pace Of Technology
Hollywood's Best Actors For The Buck
The so-called "bear hug" letter aims to pressure Genzyme to respond to the offer or justify to its shareholders why it has not held negotiations
For the year ended March 2010, Biocon's revenue was Rs 24.05 billion ($516 million)
RFCL has signed a technology transfer agreement with Hungarian company, Diagon, world leaders in Haematology reagents.
As per the understanding, the management will issue shares on preferential basis to Baring
The Lancet’s superbug report smacks of prejudice, say Indian medicos
Case to be filed under company law and not IPC as ministry absolves accused
Ranbaxy shares, which the market values at $4 bn, have dropped 13.6% so far this year
Apollo, Fortis need to go overseas to enhance their brand value
Khazanah's voluntary general offer price represents a 4.5% increase over its partial offer price
Fortis makes a profit of S$116.7 million and emerges debt-free on the deal
The shares amount to 70% of the total shares eligible to vote on the partial offer
Japan's Eisai plans to use its new plant in Andhra Pradesh to manufacture its Aricept Alzheimer's drug in India for export to Japan, the United States and Europe as early as 2011
U.S. fund manager Templeton now owns 4.97 per cent of Parkway, down from 5.04 per cent previously following a series of sales earlier this month
The U.S. District Court for New Jersey had rejected allegations by Teva and Sun Pharmaceutical that the patent on Protonix was obvious and should be declared invalid
This is in line with its forecast for its pharmaceuticals unit as key drugs like top-selling Diovan perform well
GlaxoSmithKline expects to record a legal charge of 1.57 billion pounds ($2.4 billion) for the second quarter after settling the "substantial majority" of claims relating to its controversial diabetes pill Avandia
